Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Tobramycin inhalation solution

1 clinical trial

5 indications

Indication
Cystic Fibrosis Lung
Indication
Respiratory Infections
Indication
Recurrent
Indication
Chronic
Indication
Pseudomonas aeruginosa
Clinical trial
A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects With Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection
Status: Recruiting, Estimated PCD: 2025-04-01